HUT68021A - Improved activating process of recombinant proteins - Google Patents
Improved activating process of recombinant proteinsInfo
- Publication number
- HUT68021A HUT68021A HU9200548A HU9200548A HUT68021A HU T68021 A HUT68021 A HU T68021A HU 9200548 A HU9200548 A HU 9200548A HU 9200548 A HU9200548 A HU 9200548A HU T68021 A HUT68021 A HU T68021A
- Authority
- HU
- Hungary
- Prior art keywords
- recombinant proteins
- activating process
- amino acids
- improved activating
- helper sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dental Preparations (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Adhesive Tapes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4105480A DE4105480A1 (de) | 1991-02-21 | 1991-02-21 | Verbesserte aktivierung von rekombinanten proteinen |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9200548D0 HU9200548D0 (en) | 1992-04-28 |
HUT68021A true HUT68021A (en) | 1995-04-04 |
HU214881B HU214881B (hu) | 1998-07-28 |
Family
ID=6425597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9200548A HU214881B (hu) | 1991-02-21 | 1992-02-20 | Rekombináns proteinek javított aktiválási eljárása |
Country Status (20)
Country | Link |
---|---|
US (1) | US5578710A (hu) |
EP (1) | EP0500108B1 (hu) |
JP (1) | JP2528232B2 (hu) |
KR (1) | KR950014493B1 (hu) |
AT (1) | ATE144284T1 (hu) |
AU (1) | AU641081B2 (hu) |
CA (1) | CA2061569C (hu) |
CZ (1) | CZ282744B6 (hu) |
DE (2) | DE4105480A1 (hu) |
DK (1) | DK0500108T3 (hu) |
ES (1) | ES2093122T3 (hu) |
FI (1) | FI106029B (hu) |
GR (1) | GR3021395T3 (hu) |
HU (1) | HU214881B (hu) |
IE (1) | IE920276A1 (hu) |
IL (1) | IL101024A (hu) |
MX (1) | MX9200709A (hu) |
NO (1) | NO300329B1 (hu) |
NZ (1) | NZ241570A (hu) |
ZA (1) | ZA921230B (hu) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US5581476A (en) | 1993-01-28 | 1996-12-03 | Amgen Inc. | Computer-based methods and articles of manufacture for preparing G-CSF analogs |
SE9301057L (sv) * | 1993-03-30 | 1994-10-01 | Pharmacia Ab | Beredning med kontrollerad frisättning |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
MXPA03002046A (es) | 2000-09-08 | 2003-07-24 | Massachusetts Inst Technology | Composiciones analogos de factor estimulador de colonias de granulocitos y metodos para su elaboracion. |
ES2309167T3 (es) | 2001-02-19 | 2008-12-16 | Merck Patent Gmbh | Metodo para identificar epitotes de celulas t y metodo para preparar moleculas con inmunogenicidad reducida. |
CA2452582C (en) | 2001-07-11 | 2013-01-22 | Maxygen Holdings, Ltd. | G-csf conjugates |
AU2003210052A1 (en) | 2002-03-20 | 2003-09-29 | Biopolymed Inc. | Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue |
US7666627B2 (en) * | 2002-08-08 | 2010-02-23 | Targetex Kft. | Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
WO2006055260A2 (en) | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
AU2006254543A1 (en) | 2005-06-01 | 2006-12-07 | Maxygen Holdings Ltd. | PEGylated G-CSF polypeptides and methods of producing same |
AR064235A1 (es) * | 2006-07-24 | 2009-03-25 | Tetralogic Pharmaceuticals Cor | Dipeptidos antagonistas de iap, una composicion farmaceutica que los comprende y el uso de los mismos para el tratamiento del cancer |
EP2185689A2 (en) | 2007-08-09 | 2010-05-19 | Genzyme Corporation | Method of treating autoimmune disease with mesenchymal stem cells |
WO2009046015A2 (en) | 2007-09-30 | 2009-04-09 | University Of Florida Research Foundation, Inc. | Combination therapies for treating type 1 diabetes |
US8283372B2 (en) | 2009-07-02 | 2012-10-09 | Tetralogic Pharmaceuticals Corp. | 2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic |
ES2639398T3 (es) | 2010-03-04 | 2017-10-26 | Pfenex Inc. | Método para producir proteína de interferón recombinante soluble sin desnaturalización |
JP5964757B2 (ja) | 2010-03-17 | 2016-08-03 | ラチオファーマ ゲーエムベーハー | 生物学的活性型組換えヒトg−csfを得るための方法 |
NZ603033A (en) | 2010-04-01 | 2014-06-27 | Pfenex Inc | Methods for g-csf production in a pseudomonas host cell |
EP2880169B1 (en) * | 2012-08-02 | 2017-05-17 | F. Hoffmann-La Roche AG | Method for producing monomeric and multimeric molecules and uses thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4532207A (en) * | 1982-03-19 | 1985-07-30 | G. D. Searle & Co. | Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
DK55685A (da) * | 1985-02-07 | 1986-08-08 | Nordisk Gentofte | Enzym eller enzymkompleks med proteolytisk aktivitet |
US4530787A (en) * | 1984-03-28 | 1985-07-23 | Cetus Corporation | Controlled oxidation of microbially produced cysteine-containing proteins |
US5082775A (en) * | 1984-05-11 | 1992-01-21 | Berlex Laboratories, Inc. | Efficient process for isolating insoluble heterologous protein using non-ionic detergents |
US4948729A (en) * | 1985-03-25 | 1990-08-14 | Cetus Corporation | Production of soluble recombinant proteins |
US4783415A (en) * | 1985-03-28 | 1988-11-08 | Meiji Seika Kabushiki Kaisha | Gene coding for signal peptides and utilization thereof |
US5087564A (en) * | 1985-06-20 | 1992-02-11 | Monsanto Company | Release of recombinant peptides from polypeptides using V8 endopeptidase |
DE3636903A1 (de) * | 1985-12-21 | 1987-07-02 | Hoechst Ag | Fusionsproteine mit eukaryotischem ballastanteil |
JPH0618781B2 (ja) * | 1986-10-18 | 1994-03-16 | 中外製薬株式会社 | 感染症治療剤 |
AU605291B2 (en) * | 1987-03-20 | 1991-01-10 | Micromet Ag | Process for the purification of recombinant polypeptides |
US5013653A (en) * | 1987-03-20 | 1991-05-07 | Creative Biomolecules, Inc. | Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage |
JPH03503596A (ja) * | 1987-06-24 | 1991-08-15 | ノボ・ノルディスク エー/エス | 蛋白質若しくはポリペプチドの調製方法、該ポリペプチドをコードするdna配列、該dna配列およびポリペプチドを有する微生物および該ポリペプチドの薬学的製剤としての利用 |
DE3835350A1 (de) * | 1988-10-17 | 1990-04-19 | Boehringer Mannheim Gmbh | Aktivierung von gentechnologisch hergestellten, in prokaryonten exprimierten antikoerpern |
ZA901719B (en) * | 1989-03-19 | 1991-01-30 | Akzo Nv | Hog cholera virus vaccine and diagnostics |
US5191063A (en) * | 1989-05-02 | 1993-03-02 | University Of Medicine And Dentistry Of New Jersey | Production of biologically active polypeptides by treatment with an exogenous peptide sequence |
US5115102A (en) * | 1989-07-21 | 1992-05-19 | Monsanto Company | Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
AU8417091A (en) * | 1990-08-20 | 1992-03-17 | Novo Nordisk A/S | Biologically active compound, a process for the preparation thereof and use of the same |
-
1991
- 1991-02-21 DE DE4105480A patent/DE4105480A1/de not_active Withdrawn
-
1992
- 1992-01-28 IE IE027692A patent/IE920276A1/en not_active IP Right Cessation
- 1992-02-10 NZ NZ241570A patent/NZ241570A/en not_active IP Right Cessation
- 1992-02-14 AU AU10948/92A patent/AU641081B2/en not_active Ceased
- 1992-02-20 CZ CS92499A patent/CZ282744B6/cs not_active IP Right Cessation
- 1992-02-20 FI FI920742A patent/FI106029B/fi not_active IP Right Cessation
- 1992-02-20 JP JP4033257A patent/JP2528232B2/ja not_active Expired - Lifetime
- 1992-02-20 AT AT92102864T patent/ATE144284T1/de not_active IP Right Cessation
- 1992-02-20 ES ES92102864T patent/ES2093122T3/es not_active Expired - Lifetime
- 1992-02-20 EP EP92102864A patent/EP0500108B1/de not_active Revoked
- 1992-02-20 DK DK92102864.3T patent/DK0500108T3/da active
- 1992-02-20 MX MX9200709A patent/MX9200709A/es not_active IP Right Cessation
- 1992-02-20 IL IL10102492A patent/IL101024A/en not_active IP Right Cessation
- 1992-02-20 CA CA002061569A patent/CA2061569C/en not_active Expired - Fee Related
- 1992-02-20 ZA ZA921230A patent/ZA921230B/xx unknown
- 1992-02-20 DE DE59207351T patent/DE59207351D1/de not_active Revoked
- 1992-02-20 HU HU9200548A patent/HU214881B/hu not_active IP Right Cessation
- 1992-02-20 NO NO920671A patent/NO300329B1/no unknown
- 1992-02-21 KR KR1019920002697A patent/KR950014493B1/ko not_active IP Right Cessation
-
1993
- 1993-10-21 US US08/139,054 patent/US5578710A/en not_active Expired - Lifetime
-
1996
- 1996-10-17 GR GR960402469T patent/GR3021395T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI106029B (fi) | 2000-11-15 |
NO300329B1 (no) | 1997-05-12 |
KR950014493B1 (ko) | 1995-12-02 |
DK0500108T3 (da) | 1997-03-24 |
AU1094892A (en) | 1992-08-27 |
NO920671D0 (no) | 1992-02-20 |
NZ241570A (en) | 1994-09-27 |
CA2061569C (en) | 2000-10-24 |
EP0500108B1 (de) | 1996-10-16 |
CA2061569A1 (en) | 1992-08-22 |
IL101024A0 (en) | 1992-11-15 |
GR3021395T3 (en) | 1997-01-31 |
KR920016464A (ko) | 1992-09-24 |
IE920276A1 (en) | 1992-08-26 |
JPH05244977A (ja) | 1993-09-24 |
US5578710A (en) | 1996-11-26 |
JP2528232B2 (ja) | 1996-08-28 |
FI920742A (fi) | 1992-08-22 |
MX9200709A (es) | 1992-09-01 |
EP0500108A2 (de) | 1992-08-26 |
IL101024A (en) | 1996-06-18 |
CZ282744B6 (cs) | 1997-09-17 |
EP0500108A3 (en) | 1993-04-07 |
ZA921230B (en) | 1992-11-25 |
NO920671L (no) | 1992-08-24 |
FI920742A0 (fi) | 1992-02-20 |
DE59207351D1 (de) | 1996-11-21 |
HU214881B (hu) | 1998-07-28 |
AU641081B2 (en) | 1993-09-09 |
DE4105480A1 (de) | 1992-08-27 |
ES2093122T3 (es) | 1996-12-16 |
HU9200548D0 (en) | 1992-04-28 |
ATE144284T1 (de) | 1996-11-15 |
CS49992A3 (en) | 1992-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT68021A (en) | Improved activating process of recombinant proteins | |
DE69033040D1 (de) | Verfahren zur Herstellung von biologisch aktivem Protein (z.B. TGF) | |
ATE123520T1 (de) | Kex2-endoprotease und verfahren zu ihrer herstellung. | |
CA2005502A1 (en) | Somatotropin analogs | |
FI880017A (fi) | Menetelmä haiman erittämän trypsiini-inhibiittorivarianttien valmistamiseksi ja menetelmässä käytettävä DNA, vektori ja isäntäsolu | |
DE3688324D1 (de) | Dna-sequenzen, die fuer proteine mit der biologischen aktivitaet der husi-typi-inhibitoren codieren, gentechnologische verfahren zur herstellung dieser proteine und diese proteine enthaltende arzneimittel. | |
AU669483B2 (en) | Nucleotide sequences and resistance proteins cycloheximide | |
DK0652903T3 (da) | Nyt humant rekombinant gammainterferon | |
DE68907635D1 (de) | Loetmaterial fuer brillengestelle und brillengestelle, bei denen dieses loetmaterial verwendet ist. | |
DE3852105D1 (de) | Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe. | |
FR2635527B1 (fr) | Il2 humaine recombinante non glycosylee sous forme reduite, son procede d'obtention et son application comme medicament | |
DE68923496D1 (de) | Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression. | |
IT8719551A0 (it) | Plasmidi ricombinanti utili perl'espressione in bacillus di proteine eterologhe. | |
EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
DE69534738D1 (de) | Leukocyten-aktivierender Faktor | |
GB9604518D0 (en) | Novel compounds | |
ATE76081T1 (de) | Verfahren zur herstellung von dipeptiden mit nterminalen nichtproteinogenen aminosaeuren. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |